SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.28+1.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John O'Neill who wrote (20547)5/12/1998 7:11:00 AM
From: Henry Niman   of 32384
 
JO, I think that the response will be positive, but the significance may not be appreciated for a few weeks. The situation is somewhat like the GLYC acquisition in the spring of 1995. LGND was trading in the $6-$7 range and within a few months they were into double digits (and they set their all time high of 19 3/4 within a year).

The move picked up some new shareholders and put LGND on the radar screen. MTSL and CTSL put LGND in their portfolios and Bear Stearns initiated coverage.

I think that LGND will get more coverage very soon and an NDA filing (for topical Panretin) coupled with FDA approval (for ONTAK), will generate enthusiasm from more conservative analysts and shareholders who have been watching from the sidelines.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext